We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSPR icon
13026
InspireMD
NSPR
$46M
$69K ﹤0.01%
13,693
-12,202
-47% -$73.9K
SGLY icon
13027
CALL
Singularity Future Technology
SGLY
$4.41M
$69K ﹤0.01%
154
-554
-78% -$321K
URG
13028
Ur-Energy
URG
$537M
$69K ﹤0.01%
48,994
+13,555
+38% +$18.5K
YCBD icon
13029
cbdMD
YCBD
$5.2M
$69K ﹤0.01%
66
-39
-37% -$46.7K
DXYN
13030
DELISTED
Dixie Group Inc
DXYN
$69K ﹤0.01%
23,541
-10,191
-30% -$31.4K
CYRN
13031
DELISTED
CYREN Ltd.
CYRN
$69K ﹤0.01%
4,267
-10,932
-72% -$149K
ZVO
13032
PUT
DELISTED
Zovio Inc. Common Stock
ZVO
$69K ﹤0.01%
26,800
-45,200
-63% -$138K
AQST icon
13033
PUT
Aquestive Therapeutics
AQST
$533M
$68K ﹤0.01%
17,100
-43,100
-72% -$172K
ECOR icon
13034
electroCore
ECOR
$89.9M
$68K ﹤0.01%
3,801
-14
-0.4% -$361
EEX
13035
DELISTED
Emerald Holding
EEX
$68K ﹤0.01%
12,716
-80,258
-86% -$430K
GALT icon
13036
PUT
Galectin Therapeutics
GALT
$347M
$68K ﹤0.01%
+21,100
New +$75.1K
INBS icon
13037
Intelligent Bio Solutions
INBS
$8.36M
$68K ﹤0.01%
7
-5
-42% -$47.8K
TKC icon
13038
PUT
Turkcell
TKC
$4.75B
$68K ﹤0.01%
14,500
-17,300
-54% -$81.3K
BYU
13039
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$68K ﹤0.01%
268
-345
-56% -$104K
INFI
13040
PUT
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$68K ﹤0.01%
22,800
-5,600
-20% -$17.7K
PTE
13041
PUT
DELISTED
PolarityTE, Inc. Common Stock
PTE
$68K ﹤0.01%
2,676
-128
-5% -$3.37K
ARCO icon
13042
Arcos Dorados Holdings
ARCO
$1.67B
$67K ﹤0.01%
11,373
-27,915
-71% -$164K
OPHC icon
13043
OptimumBank Holdings
OPHC
$124M
$67K ﹤0.01%
+13,920
New +$56.2K
ORC
13044
CALL
Orchid Island Capital
ORC
$1.33B
$67K ﹤0.01%
+2,600
New +$72.2K
PHX
13045
PUT
DELISTED
PHX Minerals
PHX
$67K ﹤0.01%
18,000
+6,500
+57% +$19.7K
PTN
13046
Palatin Technologies
PTN
$16.7M
$67K ﹤0.01%
+88
New +$64.1K
TISI icon
13047
Team
TISI
$101M
$67K ﹤0.01%
1,007
-485
-33% -$44.1K
VATE icon
13048
CALL
INNOVATE Corp
VATE
$109M
$67K ﹤0.01%
1,690
+550
+48% +$22.2K
NTBL
13049
PUT
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$67K ﹤0.01%
806
+492
+157% +$37.3K
TAST
13050
CALL
DELISTED
Carrols Restaurant Group, Inc.
TAST
$67K ﹤0.01%
+11,100
New +$65.5K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.